A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

NCT01254019 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophies

Interventions

DRUG: GSK2402968 6mg/kg/week

Sponsor

GlaxoSmithKline